Making the hallmarks of aging measurable and clinically actionable

Who We Are

BEYOND GENOMiX is a Swiss DeepTech platform company building the measurement layer for the biology of aging. We develop high-resolution, reproducible tools that quantify the molecular hallmarks of aging from minimal sample input, generating proprietary clinical data assets that power diagnostics for idiopathic age-related disease and biomarker services for pharmaceutical R&D.

Learn More
“Aging biology is transforming our understanding of age-related disease, but its clinical translation has been limited by the absence of scalable, standardized measurement tools. BEYOND GENOMiX is closing that gap, turning the molecular hallmarks of aging into clinical-grade data that medicine has been missing.”
Prof. Dr. Manstein, MD, PhD
Harvard Medical School
Investor · Founding Scientific Advisor

NEWS

More News
  • LEAP 2026

    BEYOND GENOMiX exhibits at LEAP 2026, presenting its precision diagnostics platform to a global innovation audience.

  • EU Funding

    BEYOND GENOMiX secured competitive European funding to accelerate its mitochondrial measurement technology.

  • ESA Moon 2040

    BEYOND GENOMiX was shortlisted for ESA's Moon 2040 programme for its crew health monitoring measurement platform.

  • WHO

    BEYOND GENOMiX shared insights on innovation priorities in the Arab world at the WHO World Health Assembly.